GILDE HEALTHCARE PARTNERS US, INC.
GILDE HEALTHCARE PARTNERS US, INC. is a Seed, Series A, Series C+, private-equity and buyout fund in the US, Europe, Germany and Benelux writing $10M–$200M checks into Climate, Healthcare, healthcare-tech, therapeutics, diagnostics, healthcare-providers, medical-products, healthcare-services, energy-transition, biodiversity and waste-and-pollution.
- Stages
- Seed, Series A, Series C+, private-equity, buyout
- Sectors
- Climate, Healthcare, healthcare-tech, therapeutics, diagnostics, healthcare-providers, medical-products, healthcare-services, energy-transition, biodiversity, waste-and-pollution
- Check size
- $10M–$200M
- Invests in
- US-wide, Europe, Germany, Benelux
- Actively investing
- Yes
- Founded
- 1982
- Assets under management
- €3B+
Thesis
Gilde Healthcare Partners US, Inc. is the U.S. arm of Gilde Healthcare Partners, a Dutch investment firm founded in 1982. The firm manages over €3 billion in AUM across three strategies: Venture&Growth in Healthcare, Private Equity in Healthcare, and Private Equity in Climate Solutions. Their investment thesis is to enable 'better care at lower cost'. The Venture&Growth strategy targets innovative healthtech and therapeutics companies (digital health, MedTech, diagnostics) in Europe and North America, with investments typically ranging from €10 million to €70 million per company, focusing on early revenue or clinical development stages. The Private Equity strategy targets profitable, lower mid-market healthcare companies in Europe (North-Western Europe, Benelux, Germany), including providers, suppliers, and service providers. They also have a Climate Solutions fund. Gilde Healthcare Partners US, Inc. operates from Boston, MA, with parent company headquarters in Utrecht, Netherlands, and an office in Frankfurt, Germany. Typical deal sizes for Venture&Growth are €10-70 million, and for Private Equity, €20-200 million, with €10-50 million deals being common.
Common questions
Does GILDE HEALTHCARE PARTNERS US, INC. invest at the Seed stage?
Yes. GILDE HEALTHCARE PARTNERS US, INC. lists Seed, Series A, Series C+, private-equity and buyout among the stages it invests in.
What check size does GILDE HEALTHCARE PARTNERS US, INC. write?
GILDE HEALTHCARE PARTNERS US, INC. writes $10M–$200M checks.
Where does GILDE HEALTHCARE PARTNERS US, INC. invest?
GILDE HEALTHCARE PARTNERS US, INC. invests in the US, Europe, Germany and Benelux.